Market Overview:
The global Vardenafil market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented by type, application and region. By type, the market is segmented into 2.5 mg tablet, 5 mg tablet, 10 mg tablet and 20 mg tablet. By application, the market is divided into hospital and drug store segments. Geographically, the market is analyzed across North America, Latin America, Europe Asia Pacific and Middle East & Africa. Some of the key players in this industry are Pfizer Inc., Bayer AG., Eli Lilly & Co., Teva Pharmaceutical Industries Ltd.
Product Definition:
Vardenafil is a phosphodiesterase type 5 inhibitor. It helps to relax muscles and increase blood flow to particular areas of the body. Vardenafil is used to treat erectile dysfunction (impotence) in men and pulmonary arterial hypertension (high blood pressure in the lungs).
2.5 mg Tablet:
2.5 mg tablet is used for the treatment of Erectile Dysfunction (ED) and pulmonary arterial hypertension in adults. It works by relaxing the smooth muscles in the penis, allowing more blood into the corpora cavernosa during sexual stimulation. Vardenafil tablets are also used to treat muscle rheumatism and pain caused by osteoarthritis; it is also prescribed as an anti-inflammatory drug to reduce swelling and prevent joint damage after an injury or surgery.
5 mg Tablet:
5 mg tablet is used for the treatment of Erectile Dysfunction (ED) and premature ejaculation. It works by relaxing the muscles in the penis, which enables it to become erect. Vardenafil tablets are also used to treat symptoms of benign prostatic hyperplasia such as urinary urgency, weak urine stream, and frequent urination.
Application Insights:
The drug store segment held the largest share of more than 60.0% in 2017. Rising awareness regarding male infertility is expected to boost demand for vardenafil tablets over the forecast period from 2018 to 2030. Increasing cases of impotence among middle-aged and older men are also expected to drive demand for this medicine in future years.
Hospital application is projected register a CAGR of XX% from 2018 to 2030 owing to rising adoption of VARD as an effective treatment option against Erectile Dysfunction (ED) in clinical trials conducted thus far, which has established its safety and efficacy profile as a prescription drug under regulatory guidelines for treating ED, resulting in increased product consumption by hospitals and clinics around the world since its launch about two decades ago till date.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers coupled with high R&D expenditure by companies is expected to drive the regional growth over the forecast period. In addition, increasing cases of erectile dysfunction among aging population and growing awareness about available treatment options are also expected to propel demand for vardenafil tablets in this region.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to rising healthcare spending, improving economic conditions and expanding patient pool in emerging countries such as China and India. Moreover, increasing prevalence of cardiovascular diseases among Asian populations has led them to prefer safer therapies for management of sexual disorders which will further boost demand over coming years. ‘’VAR-1035; Ocuvite 100 mg/ml Solution; Ocuvite Pharmaceuticals Pvt Ltd.
Growth Factors:
- Increasing prevalence of erectile dysfunction (ED) due to changing lifestyle habits and increasing aging population.
- Growing awareness about the benefits of Vardenafil over other treatment options for ED.
- Launch of new generic versions of Vardenafil by various manufacturers, which will help in reducing the cost of treatment and making it more affordable for patients.
- Rising demand for oral ED drugs owing to their ease-of-use and faster onset of action as compared to injectable drugs or penile implants.
Scope Of The Report
Report Attributes
Report Details
Report Title
Vardenafil Market Research Report
By Type
2.5 mg Tablet, 5 mg Tablet, 10 mg Tablet, 20 mg Tablet
By Application
Hospital, Drug store
By Companies
Bayer, GSK, Teva, Par Pharmaceutical, Alembic Pharmaceuticals, Macleods Pharmaceuticals, Zydus Pharmaceuticals, Crossmedika SA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Vardenafil Market Report Segments:
The global Vardenafil market is segmented on the basis of:
Types
2.5 mg Tablet, 5 mg Tablet, 10 mg Tablet, 20 mg Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- GSK
- Teva
- Par Pharmaceutical
- Alembic Pharmaceuticals
- Macleods Pharmaceuticals
- Zydus Pharmaceuticals
- Crossmedika SA
Highlights of The Vardenafil Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2.5 mg Tablet
- 5 mg Tablet
- 10 mg Tablet
- 20 mg Tablet
- By Application:
- Hospital
- Drug store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vardenafil Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vardenafil is a medication used to treat erectile dysfunction (ED). It works by helping the blood flow more easily in the penis during sexual activity.
Some of the major companies in the vardenafil market are Bayer, GSK, Teva, Par Pharmaceutical, Alembic Pharmaceuticals, Macleods Pharmaceuticals, Zydus Pharmaceuticals, Crossmedika SA.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vardenafil Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vardenafil Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vardenafil Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vardenafil Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vardenafil Market Size & Forecast, 2020-2028
4.5.1 Vardenafil Market Size and Y-o-Y Growth
4.5.2 Vardenafil Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 2.5 mg Tablet
5.2.2 5 mg Tablet
5.2.3 10 mg Tablet
5.2.4 20 mg Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vardenafil Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vardenafil Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 2.5 mg Tablet
9.6.2 5 mg Tablet
9.6.3 10 mg Tablet
9.6.4 20 mg Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 2.5 mg Tablet
10.6.2 5 mg Tablet
10.6.3 10 mg Tablet
10.6.4 20 mg Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 2.5 mg Tablet
11.6.2 5 mg Tablet
11.6.3 10 mg Tablet
11.6.4 20 mg Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 2.5 mg Tablet
12.6.2 5 mg Tablet
12.6.3 10 mg Tablet
12.6.4 20 mg Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 2.5 mg Tablet
13.6.2 5 mg Tablet
13.6.3 10 mg Tablet
13.6.4 20 mg Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vardenafil Market: Competitive Dashboard
14.2 Global Vardenafil Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 GSK
14.3.3 Teva
14.3.4 Par Pharmaceutical
14.3.5 Alembic Pharmaceuticals
14.3.6 Macleods Pharmaceuticals
14.3.7 Zydus Pharmaceuticals
14.3.8 Crossmedika SA
